You own 1.7 % of $DTIL. Have you talked to management at all? If so do they have much bigger picture longer term ideas for Precision? Also risk of more dilution ?

Yes i speak with them regularly. Of course they will dilute, hopefully slowly, at the right price. They are focused on executing ph1 protocols, and pipeline out-licensing. I beg them to find a partner for HBV ph3 program development but they are more interested in selling rights.